vs
GETTY REALTY CORP（GTY）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是GETTY REALTY CORP的1.3倍（$75.5M vs $57.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 10.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.6%）
Getty Realty Corp是一家总部位于美国的上市房地产投资信托（REIT），主要持有、租赁并管理商业地产资产组合，核心资产涵盖便利店、加油站及配套零售物业，业务覆盖美国多个州，服务零售与能源领域的优质租户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GTY vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$57.8M
营收增速更快
PBYI
高出17.2%
10.5%
两年增速更快
PBYI
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.8M | $75.5M |
| 净利润 | $26.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 66.1% | 22.7% |
| 净利率 | 46.0% | — |
| 营收同比 | 10.5% | 27.7% |
| 净利润同比 | 80.1% | — |
| 每股收益（稀释后） | $0.43 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTYPBYI
| Q1 26 | $57.8M | — | ||
| Q4 25 | $60.5M | $75.5M | ||
| Q3 25 | $55.6M | $54.5M | ||
| Q2 25 | $53.3M | $52.4M | ||
| Q1 25 | $52.3M | $46.0M | ||
| Q4 24 | $53.0M | $59.1M | ||
| Q3 24 | $51.5M | $80.5M | ||
| Q2 24 | $49.9M | $47.1M |
净利润GTYPBYI
| Q1 26 | $26.6M | — | ||
| Q4 25 | $27.0M | — | ||
| Q3 25 | $23.3M | $8.8M | ||
| Q2 25 | $14.0M | $5.9M | ||
| Q1 25 | $14.8M | $3.0M | ||
| Q4 24 | $22.3M | — | ||
| Q3 24 | $15.3M | $20.3M | ||
| Q2 24 | $16.7M | $-4.5M |
毛利率GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率GTYPBYI
| Q1 26 | 66.1% | — | ||
| Q4 25 | 67.3% | 22.7% | ||
| Q3 25 | 62.5% | 17.6% | ||
| Q2 25 | 46.7% | 12.7% | ||
| Q1 25 | 50.5% | 8.7% | ||
| Q4 24 | 61.6% | 22.6% | ||
| Q3 24 | 48.9% | 27.4% | ||
| Q2 24 | 52.5% | -4.6% |
净利率GTYPBYI
| Q1 26 | 46.0% | — | ||
| Q4 25 | 44.7% | — | ||
| Q3 25 | 42.0% | 16.2% | ||
| Q2 25 | 26.3% | 11.2% | ||
| Q1 25 | 28.3% | 6.5% | ||
| Q4 24 | 42.1% | — | ||
| Q3 24 | 29.8% | 25.2% | ||
| Q2 24 | 33.5% | -9.6% |
每股收益（稀释后）GTYPBYI
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.46 | $0.26 | ||
| Q3 25 | $0.40 | $0.17 | ||
| Q2 25 | $0.24 | $0.12 | ||
| Q1 25 | $0.25 | $0.06 | ||
| Q4 24 | $0.38 | $0.40 | ||
| Q3 24 | $0.27 | $0.41 | ||
| Q2 24 | $0.30 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | — | $130.3M |
| 总资产 | $2.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GTYPBYI
| Q1 26 | $3.7M | — | ||
| Q4 25 | $8.4M | $97.5M | ||
| Q3 25 | $5.2M | $94.4M | ||
| Q2 25 | $7.5M | $96.0M | ||
| Q1 25 | $6.3M | $93.2M | ||
| Q4 24 | $9.5M | $101.0M | ||
| Q3 24 | $4.0M | $96.7M | ||
| Q2 24 | $4.7M | $96.8M |
总债务GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | $995.0M | $22.7M | ||
| Q3 25 | $934.6M | $34.0M | ||
| Q2 25 | $919.2M | $45.3M | ||
| Q1 25 | $901.4M | $56.7M | ||
| Q4 24 | $904.3M | $68.0M | ||
| Q3 24 | $833.9M | $79.3M | ||
| Q2 24 | $838.4M | $90.7M |
股东权益GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $130.3M | ||
| Q3 25 | $1.0B | $115.3M | ||
| Q2 25 | $982.4M | $104.7M | ||
| Q1 25 | $961.1M | $97.1M | ||
| Q4 24 | $962.1M | $92.1M | ||
| Q3 24 | $963.4M | $71.1M | ||
| Q2 24 | $951.0M | $48.5M |
总资产GTYPBYI
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $216.3M | ||
| Q3 25 | $2.1B | $202.9M | ||
| Q2 25 | $2.0B | $194.9M | ||
| Q1 25 | $2.0B | $196.2M | ||
| Q4 24 | $2.0B | $213.3M | ||
| Q3 24 | $1.9B | $220.7M | ||
| Q2 24 | $1.9B | $205.0M |
负债/权益比GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.93× | 0.17× | ||
| Q3 25 | 0.92× | 0.30× | ||
| Q2 25 | 0.94× | 0.43× | ||
| Q1 25 | 0.94× | 0.58× | ||
| Q4 24 | 0.94× | 0.74× | ||
| Q3 24 | 0.87× | 1.12× | ||
| Q2 24 | 0.88× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | $127.4M | $14.4M | ||
| Q3 25 | $30.5M | $9.7M | ||
| Q2 25 | $34.7M | $14.1M | ||
| Q1 25 | $28.7M | $3.6M | ||
| Q4 24 | $130.5M | $15.6M | ||
| Q3 24 | $34.6M | $11.0M | ||
| Q2 24 | $29.7M | $1.0M |
自由现金流GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | $127.0M | $14.4M | ||
| Q3 25 | $30.4M | $9.7M | ||
| Q2 25 | $34.6M | $14.1M | ||
| Q1 25 | $28.6M | $3.6M | ||
| Q4 24 | $129.6M | $15.6M | ||
| Q3 24 | $34.4M | $11.0M | ||
| Q2 24 | $29.6M | $1.0M |
自由现金流率GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | 209.8% | 19.1% | ||
| Q3 25 | 54.7% | 17.7% | ||
| Q2 25 | 64.9% | 26.8% | ||
| Q1 25 | 54.7% | 7.7% | ||
| Q4 24 | 244.5% | 26.4% | ||
| Q3 24 | 66.9% | 13.7% | ||
| Q2 24 | 59.2% | 2.1% |
资本支出强度GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 1.7% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% |
现金转化率GTYPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.71× | — | ||
| Q3 25 | 1.31× | 1.10× | ||
| Q2 25 | 2.48× | 2.41× | ||
| Q1 25 | 1.94× | 1.21× | ||
| Q4 24 | 5.85× | — | ||
| Q3 24 | 2.26× | 0.54× | ||
| Q2 24 | 1.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
